G7 takes aim at China: World's richest nations unite to crush unfair trade tactics
According to the latest Yahoo Finance report, while U.S. tariffs and other prickly issues emerged over the Group of Seven (G7) conference, bureaucrats opted to highlight accord and compromise over conflict, putting aside their conventional free trade grandstanding to agree on larger economic objectives.
The concluding announcement avoided directly naming China but indicated a united concern over 'nonmarket policies and practices,' usually a contraction of China's export restrictions and currency controls. U.S. Treasury Secretary Scott Bessent was influential in creating the language to integrate and conform with the Trump government's hard-hitting posture on trade. Sidestepping the tariff tensions
Principally, U.S. tariffs went untouched in the statement, a silence that mirrors both detachment and tact. President Trump's all-encompassing tariffs on partners, including aluminum, cars, and steel were a breaking point in the background. Yet, in a move carped by several onlookers as powerless, the statement dodged the subject matter.
European Union Trade Commissioner Valdis Dombrovskis accepted that tariffs persisted to be a 'difficult topic,' with consultations avoided in agreement with bilateral discussions between the U.S. and specific G7 members. Detractors such as former Treasury official Mark Sobel thumped the statement for the absence of truthfulness, identifying it as 'feeble' and blind to the apparent cracks within the group. Ukraine support is steady but softened
On geopolitical questions, the G7 reiterated its backing for Ukraine but employed subdued language compared to the previous years. The group denounced Russia's continuing hostility but sidestepped past word forms such as 'unjustifiable' or 'full-scale invasion,' echoing the Trump regime's careful slant toward Russia.
A prominent passage in the communiqué stated that no nation backing up Russia's war struggle would be allowed to gain from Ukraine's imminent rebuilding—a strong signal intended for China. The group likewise reiterated its promise to keep Russian resources frozen and implied additional reprisal measures if the armistice remains elusive. See also Nike pulls US sneaker featuring slavery-era flag Climate, taxes, and the forgotten priorities
Unity as the prime objective came at a cost. Vital issues like climate change and worldwide tax collaboration—once pillars of G7 pronouncements, were noticeably non-existent from this year's statement. This oversight mirrors a tactical move to focus on primary economic questions, particularly campaigned by the U.S., instead of longstanding worldwide initiatives.
Canadian Finance Minister François-Philippe Champagne recognised the compromises and the cost-benefit decisions. 'There will always be tension around tariffs,' he said. 'But this year our focus was to return to the G7 core mission—restoring global growth and stability.'
With the G7 leaders' high-level meeting slated for mid-June in Kananaskis, the foundation is laid, but the route ahead is undefined. As political scientist John Kirton said, the sheer presence of a communiqué is a political triumph in itself, but the indicators' lasting unity or provisional concession remains to be seen.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
an hour ago
- Straits Times
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday. The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts said. Pharmaceuticals had historically been exempt from duties. Medicines are the largest European exports to the United States by value and the EU accounts for about 60% of all pharmaceutical imports to the U.S. On Sunday, European officials said that a bilateral trade deal for an across-the-board 15% tariff included pharmaceuticals, except for some generic drugs, which would be subject to no tariffs. The U.S. has been conducting a national security investigation into the pharmaceutical sector and the industry has been bracing for separate sectoral tariffs. President Donald Trump said earlier this month, before negotiating the bilateral deal, that pharmaceutical tariffs could be as high as 200%. Some Wall Street analysts said that they do not expect additional tariffs on the EU as a result of the investigation, but others cautioned that the deal was not yet signed and that several questions remained unanswered. UBS analyst Matthew Weston said that he expects details of the trade deal to include protective measures for EU pharma exports from the U.S. investigation, especially since such measures are being discussed in negotiations with the United Kingdom and Switzerland. Top stories Swipe. Select. Stay informed. Asia Cambodia, Thailand agree to 'immediate and unconditional ceasefire' to de-escalate border row Singapore Tanjong Katong sinkhole: Road recovery works progressing steadily, tests under way Singapore ST Explains: What we know about the Tanjong Katong sinkhole so far Singapore Foreign workers who rescued woman from sinkhole given tokens of appreciation Sport Gan Ching Hwee breaks 2 national records, qualifies for World Aquatics C'ships 1,500m final Asia Gunman kills 5 near Bangkok's Chatuchak market before taking own life Business SIA Q1 profit falls 59%; airline group sees volatile times ahead Singapore Man exposed daughter's identity despite court order after she was removed from his care ING analyst Diederik Stadig also said that while tariffs on top of the 15% were not expected, even after the conclusion of the national security investigations, nothing is completely clear "until a trade deal is inked." Stadig estimates that these levies could add $13 billion to industry expenses without any mitigation strategies, and some of that could be ultimately borne by the consumer. Bernstein analyst Courtney Breen puts the additional expenses at $19 billion for the industry, but she notes that companies might be able to absorb some of the costs with the measures they have been implementing — such as stockpiling of drug products and new deals with contract researchers. Earlier this month, Sanofi said it will sell a manufacturing facility in New Jersey to Thermo Fisher, where the French drugmaker's therapies will continue to be manufactured. Roche's CEO Thomas Schinecker said last week that the company was increasing its U.S. inventories to avoid any immediate disruption from tariffs. UBS' Weston said that it was not immediately clear which generic drugs were exempted from duties under the deal, but any impact for generic drugmaker Sandoz for this year should mostly be manageable. Shares in pharmaceutical companies Sanofi, Roche and Sandoz Group all closed up between 0.5% and 1% on Monday. REUTERS
International Business Times
2 hours ago
- International Business Times
Global Markets Surge as US-EU Trade Deal Eases Investor Anxiety
The global stock benchmarks opened the week with firm gains, driven by a return of investor risk appetite after progress on trade talks between the US and EU. Futures tracking the S&P 500 in the United States rose 0.45%, while those for the Nasdaq gained 0.5%, pointing to a robust start on Wall Street. European stock futures were also up by almost 1%, supported by the relief in trade tensions. The MSCI's broadest index of shares outside Japan rose 0.27% in Asia, remaining close to the four-year high it touched last week. Japan's Nikkei index declined 0.8%, pulling back after its recent rally to a one-year peak. The euro rose significantly against the U.S. dollar, British pound, and Japanese yen as the market welcomed the deal, reflecting market's positive response to the deal. US-EU Trade Agreement Brings Relief Markets rallied on news that the United States and the European Union had reached a framework trade deal. Under the deal, the administration agreed to apply a 15% tariff on most European goods entering the United States, well below the 30% rate it had previously threatened. The deal is regarded as a compromise with gains for both countries, and it diminishes the near-term risk of a full-blown trade war. freepik The U.S. had also recently reached a similar pact with Japan to reduce vehicle import tariffs. These back-to-back deals are part of a broader effort by the Trump administration to wrap up global trade before the August 1 deadline. Meantime, the U.S. and China have opened trade talks in Stockholm with hopes of extending their current ceasefire on tariffs. Clarity Brings Optimism to investors Market analysts say the recent agreement with Europe has added some clarity to businesses and investors struggling through months of uncertainty. "This deal defuses a significant risk and is part of a broader move back toward stability and predictability in trade policy," said Marc Velan, head of investments at Lucerne Asset Management. European leaders had previously hoped for a zero-tariff agreement, but the new 15% rate is considered a positive result compared to the 30% that was on the horizon. Investors are also viewing the trade news as a sign that the U.S. is choosing diplomacy over belligerent trade moves. China's CSI 300 index in Asian markets added 0.3%, led by gains in financials and in the consumer sector. Hong Kong's Hang Seng index rose 0.75%, and the Australian dollar, which is often used as a liquid proxy for global risk, was near an eight-month peak at $0.657. Focus Shifts to Fed and BOJ With the trade tensions easing, investors are turning their attention to two key central bank meetings scheduled this week, one from the U.S. Federal Reserve and another from the Bank of Japan. Both central banks are anticipated to keep interest rates on hold, but traders will be listening closely for any indications as to what comes next, particularly given shifting inflation data. The White House is keeping up the pressure on the Federal Reserve. President Trump has regularly lambasted Fed Chair Jerome Powell for keeping interest rates high and failing to do enough to pump up the economy. Two of Trump's Fed Board appointees have signaled that they would be open to lowering rates if inflation stays low. Economists say that the Fed's direction will probably be influenced by future economic data. "The PCE inflation index and July jobs report are going to be crucial to shape expectations post this meeting," said Kieran Williams, head of Asia FX at InTouch Capital Markets. If inflation keeps cooling, a policy change might be postponed until September. Oil Jumps, Gold Slides, as Risk Assets Rally The commodities market was also buoyed by the better trade outlook. Oil prices inched up, with Brent crude and U.S. West Texas Intermediate both up about 0.5%. The increases were largely on expectations for stronger demand and less global trade friction after the U.S.-EU deal.
Straits Times
2 hours ago
- Straits Times
Trump eyes 'world tariff' of 15-20% for most countries
A container is loaded onto a cargo ship while docked at a port under the Port Authority of Thailand, following the announcement that U.S. President Donald Trump would impose tariffs of 36% on goods from Thailand starting on August 1, in Bangkok, Thailand, July 8, 2025. REUTERS/Athit Perawongmetha/File Photo TURNBERRY, Scotland - President Donald Trump said on Monday most trading partners that do not negotiate separate trade deals would soon face tariffs of 15% to 20% on their exports to the United States, well above the broad 10% tariff he imposed in April. Trump told reporters his administration will notify some 200 countries soon of their new "world tariff" rate. "I would say it'll be somewhere in the 15 to 20% range," Trump told reporters, sitting alongside British Prime Minister Keir Starmer at his luxury golf resort in Turnberry, Scotland. "Probably one of those two numbers." Trump, who has vowed to end decades of U.S. trade deficits by imposing tariffs on nearly all trading partners, has already announced higher rates of up to 50% on some countries, including Brazil, starting on Friday. The announcements have spurred feverish negotiations by a host of countries seeking lower tariff rates, including India, Pakistan, Canada, and Thailand, among others. The U.S. president on Sunday clinched a huge trade deal with the European Union that includes a 15% tariff on most EU goods, $600 billion of investments in the U.S. by European firms, and $750 billion in energy purchases over the next three years. That followed a $550-billion deal with Japan last week and smaller agreements with Britain, Indonesia, and Vietnam. Other talks are ongoing, including with India, but prospects have dimmed for many more agreements before Friday, Trump's deadline for deals before higher rates take effect. Trump has repeatedly said he favors straightforward tariff rates over complex negotiations. "We're going to be setting a tariff for essentially, the rest of the world," he said again on Monday. "And that's what they're going to pay if they want to do business in the United States. Because you can't sit down and make 200 deals." Canadian Prime Minister Mark Carney said on Monday trade talks with the U.S. were at an intense phase, conceding that his country was still hoping to walk away with a tariff rate below the 35% announced by Trump on some Canadian imports. Carney conceded this month that Canada - which sends 75% of its exports to the United States - would likely have to accept some tariffs. REUTERS
